Clinical Trials Directory

Trials / Completed

CompletedNCT01809665

ProMRI PROVEN Master Study

Master Study for the MRI Compatibility of the Solia S and Solia T Pacing Lead, the Linoxsmart ProMRI and Linoxsmart ProMRI DF4 ICD (Implantable Cardioverter-defibrillator) Lead and the Corox ProMRI OTW Coronary Sinus Lead in Combination With the Ilesto/Iforia ICD or the Evia/Entovis Triple Chamber Pacemaker

Status
Completed
Phase
Study type
Observational
Enrollment
174 (actual)
Sponsor
Biotronik SE & Co. KG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This investigation is designed to provide supporting evidence for the clinical safety of the Ilesto/Iforia ICD (implantable cardioverter-defibrillator)system and the Evia/Entovis HF-T (Heart Failure) triple chamber pacemaker system when used under specific MRI (magnetic resonance imaging) conditions.

Conditions

Interventions

TypeNameDescription
DEVICEICD/CRT-P therapy
OTHERMRI

Timeline

Start date
2013-06-01
Primary completion
2015-05-01
Completion
2015-09-01
First posted
2013-03-13
Last updated
2016-03-02

Locations

23 sites across 8 countries: Australia, Austria, Canada, Czechia, France, Germany, Hungary, Switzerland

Source: ClinicalTrials.gov record NCT01809665. Inclusion in this directory is not an endorsement.

ProMRI PROVEN Master Study (NCT01809665) · Clinical Trials Directory